Skip to main content
logo
Aurobindo Pharma Limited (NSE:AUROPHARMA)
India flag India · Delayed Price · Currency is INR
1,314.20
+6.40 (0.49%)
At close: Mar 27, 2026

Aurobindo Pharma Revenue

Aurobindo Pharma had revenue of 86.46B INR in the quarter ending December 31, 2025, with 8.36% growth. This brings the company's revenue in the last twelve months to 331.82B, up 7.31% year-over-year. In the fiscal year ending March 31, 2025, Aurobindo Pharma had annual revenue of 317.24B with 9.39% growth.

Revenue (ttm)
331.82B
Revenue Growth
+7.31%
P/S Ratio
2.30
Revenue / Employee
11.98M
Employees
27,707
Market Cap
763.29B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025317.24B27.22B9.39%
Mar 31, 2024290.02B41.46B16.68%
Mar 31, 2023248.55B14.00B5.97%
Mar 31, 2022234.55B-13.19B-5.32%
Mar 31, 2021247.75B16.76B7.26%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Cipla279.67B
Zydus Lifesciences260.89B
Glenmark Pharmaceuticals165.10B
Alkem Laboratories142.53B
Mankind Pharma139.14B
Divi's Laboratories103.14B
Ipca Laboratories95.06B
Emcure Pharmaceuticals88.50B
Revenue Rankings

Aurobindo Pharma News

More News